Ten-year pivotal data reinforce the long-term durability of Edwards' Resilia Tissue
May 04, 2026
Singapore, May 4: Edwards Lifesciences, the leading global structural heart innovation company, recently announced 10-year results from the COMMENCE aortic trial, reinforcing the long-term...